[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fwyYydFzO1k2B4QE-5GGettsWJi845Qr40R3pb_GObvc":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"cae2fb1a-cb0f-45c6-a3f0-0ccf76be0d6a",{"_id":6,"slug":7,"title":8},"c098646c-9061-4278-96a9-6a3e9a140b5a","events","Events",null,"2022-01-11T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc17","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b17p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s17p1","span",[],"Investors interested in human tissue regeneration will find KLISBio at the Biotech Showcase (January 10-19), where this international medtech company is displaying its silk-based biomedical technology and flagship product, SILKBridge.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b17p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s17p2",[],"The organization specializes in restorative surgical procedures utilizing engineered silk materials. These materials offer biological and mechanical properties suitable for treating peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears, and conditions requiring sustained drug delivery. Silk fibroin demonstrates full biocompatibility while encouraging cell growth and in-vivo tissue regeneration.",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b17p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s17p3",[],"SILKBridge represents the company's first product — a silk-based graft for peripheral nerve repair. Developed from pure silk fibroin, this tissue-engineered technology balances biomechanical and biological properties, combining native silk fiber strength with electrospun silk's improved biomimicry. Clinical availability is anticipated in 2023.",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b17p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s17p4",[],"Additional products in development include vascular grafts, rotator cuff repair solutions, bone grafts, and drug-release technologies. The company holds patents in silk fibroin combinations, silk-based composites, and core-shell silk nanofibers.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b17p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s17p5",[],"CEO and co-founder Gabriele Grecchi stated the company aims to challenge the status quo in regenerative medicine by leveraging silk as a biocompatible scaffold material across orthopedic, vascular, and drug-release markets.",[],"klisbio-biotech-showcase-2022","KLISBio to feature engineered silk innovation at Biotech Showcase"]